Eisai
4523.T
#2179
Rank
HK$65.91 B
Marketcap
HK$233.65
Share price
0.17%
Change (1 day)
2.68%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$29.34 Billion

According to Eisai's latest financial reports the company's total liabilities are HK$29.34 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31HK$27.01 B5.62%
2024-03-31HK$25.57 B-1.43%
2023-03-31HK$25.94 B-13.78%
2022-03-31HK$30.09 B18.41%
2021-03-31HK$25.41 B-1.95%
2020-03-31HK$25.92 B-12.63%
2019-03-31HK$29.66 B-7.6%
2018-03-31HK$32.10 B7.37%
2017-03-31HK$29.90 B9.2%
2016-03-31HK$27.38 B-6.15%
2015-03-31HK$29.18 B-12.62%
2014-03-31HK$33.39 B-21.38%
2013-03-31HK$42.48 B-21.99%
2012-03-31HK$54.45 B-8.22%
2011-03-31HK$59.33 B5.42%
2010-03-31HK$56.28 B0.2%
2009-03-31HK$56.17 B10.19%
2008-03-31HK$50.97 B234.92%
2007-03-31HK$15.22 B0.93%
2006-03-31HK$15.08 B2.55%
2005-03-31HK$14.70 B-0.18%
2004-03-31HK$14.73 B9.35%
2003-03-31HK$13.47 B23.56%
2002-03-31HK$10.90 B-13.01%
2001-03-31HK$12.53 B